射波刀治疗老年早期非小细胞肺癌的治疗效果与安全性.docx

射波刀治疗老年早期非小细胞肺癌的治疗效果与安全性.docx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多

射波刀治疗老年早期非小细胞肺癌的治疗效果与安全性

李雪汪延明田芹张弘旺

[中图分类号]?R734.2;R730.55????[文献标识码]?A????[DOI]?10.3969/j.issn.1673-9701.2024.05.012

Efficacy?and?safety?of?cyberknife?in?the?treatment?of?elderly?patients?with?early?stage?non-small?cell?lung?cancer

LI?Xue1,2,?WANG?Yanming2,?TIAN?Qin3,?ZHANG?Hongwang1,2

1.Postgraduate?Training?Base?of?960th?Hospital?of?PLA,?Jinzhou?Medical?University,?Jinzhou?121012,?Liaoning,?China;?2.Department?of?Radiation?Oncology,?960th?Hospital?of?PLA,?Jinan?250031,?Shandong,?China;?3.Department?of?Radiation?Oncology,?Shandong?Provincial?Third?Hospital,?Jinan?250031,?Shandong,?China

[Abstract]?Objective?To?investigate?the?efficacy?and?safety?of?Cyberknife?in?the?treatment?of?elderly?patients?(aged≥75?years)?with?early?stage?non-small?cell?lung?cancer?(NSCLC),?and?to?compare?the?results?with?those?of?patients?aged?75?years.?Methods?We?retrospectively?analyzed?75?patients?with?early?(T1-2N0M0)?NSCLC?admitted?to?the?960th?Hospital?of?Jinan?Peoples?Liberation?Army?from?January?2013?to?October?2019.?There?were?32?(42.7%)?patients?aged?75?years,?and?43?(57.3%)?patients?aged≥75?years.?All?patients?were?treated?with?45–66Gy/3–8F,?60%–85%?isodose?line?as?the?prescription?dose?to?cover?planning?target?volume?(PTV),?and?irradiation?once?a?day?and?five?times?a?week.?The?clinical?efficacy,?survival?status?and?radiotherapy?toxicity?of?the?two?groups?were?compared,?and?the?factors?affecting?the?efficacy?of?elderly?patients?were?analyzed.?Results?The?disease?control?rates?of?patients?aged??75?and?≥75?years?were?96.9%?and?93.0%,?respectively?(P0.05).?The?5-year?local?control?rate?(LC),?progression-free?survival?(PFS)?and?cancer-specific?survival?(CSS)?were?70.9%?and?85.4%,?58.5%?and?54.4%,?and?70.4%?and?64.5%,?respectively?(P0.05).?However,?the?overall?survival?(OS)?of?patients?aged≥75?years?was?significantly?lower?than?that?of?patients?aged?75?years,?and?the?5-year?OS?was?49.2%?and?68.2%,?respectively?(P0.05).?There?was?no?significant?difference?in?the?treatment?compli

文档评论(0)

fdfdsos + 关注
实名认证
内容提供者

该用户很懒,什么也没介绍

版权声明书
用户编号:7100020006000001

1亿VIP精品文档

相关文档